We found modest but nonsignificant postintervention decreases in CD38 expression in the GE and IE CFS/ME groups, which reduced CD38 to much the same level as in the CTL group. This evidence concerns the gene CD38 and myalgic encephalomeyelitis/chronic fatigue syndrome.